An estimated 32 million people globally have heart failure with reduced ejection fraction, a condition where the lower left ...

Squeezed by insurers and middlemen, independent pharmacists such as Mr Jolley find themselves on the front lines of a tariff storm. Nearly everyone down the line — drugmakers, pharmacies, wholesalers, ...

The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara (ustekinumab).